non glp 1 weight loss medication Comparing Ozempic, Wegovy and Other GLP-1 Drugs A Guide to Weight-Loss Medications:

For patients with heart failure or chronic kidney disease, SGLT2 inhibitors are generally preferred first, with GLP-1 agonists considered when SGLT2 inhibitors are contraindicated or not tolerated

[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Velji-Ibrahim J, et al

People who want a simple, visual food guide

Findings from some of these models have been difficult to interpret since in certain studies the GLP-1 receptor agonists concomitantly affected glucose homeostasis, which is itself usually associated with reduced kidney injury, independent of the mode of glucose lowering

Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients